WORK Medical Technology Group LTD
WOK
Analytical Summary
WORK Medical Technology Group LTD faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.
4-Year Financial Trajectory
AnnualBullish Indicators
- No bullish signals detected.
Bearish Risks
- Profit Margin (%)Profit Margin (%) is in the bottom quartile
Health Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | FY 2025 Sep 30, 2025 20-F ↗ | FY 2024 Sep 30, 2024 20-F ↗ | FY 2023 Sep 30, 2023 20-F ↗ | FY 2022 Sep 30, 2022 20-F ↗ |
|---|---|---|---|---|
| Revenue Growth YoY (%) |
-14.4%
Weak
↑
Weak
Improving
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Below avg (-280%)
|
-15.2%
Weak
Weak
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Below avg (-290%)
|
-31.2%
Weak
Weak
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Below avg (-490%)
|
— |
| EPS Growth YoY (%) |
85.2%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M |
-85.7%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
— |
| Net Income Growth YoY (%) |
69.3%
Excellent
Excellent
Year-over-year change in net income |
N/M |
-87.1%
Weak
Weak
Year-over-year change in net income |
— |
| Revenue CAGR 3Y (%) |
-20.6%
Weak
Weak
Compound annual revenue growth over 3 years |
— | — | — |
| Metric | FY 2025 Sep 30, 2025 20-F ↗ | FY 2024 Sep 30, 2024 20-F ↗ | FY 2023 Sep 30, 2023 20-F ↗ | FY 2022 Sep 30, 2022 20-F ↗ |
|---|---|---|---|---|
| Effective Tax Rate (%) (%) |
-11.0%
Excellent
↓
Excellent
Declining
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
3.4%
Excellent
↓
Excellent
Declining
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
42.6%
Weak
Weak
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
15.2%
Good
Good
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
| Profit Margin (%) (%) |
-10.9%
Weak
↓
Weak
Declining
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-191%)
|
-30.4%
Weak
↓
Weak
Declining
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-353%)
|
0.8%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-93%)
|
4.4%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-63%)
|
| FCF Margin (%) (%) |
49.9%
Excellent
↑
Excellent
Improving
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
-99.5%
Weak
↓
Weak
Declining
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
12.9%
Fair
Fair
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
-21.7%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
| FCF / Net Income (x) |
-4.58x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
3.28x
Excellent
↓
Excellent
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
15.66x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
-4.94x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
| Metric | FY 2025 Sep 30, 2025 20-F ↗ | FY 2024 Sep 30, 2024 20-F ↗ | FY 2023 Sep 30, 2023 20-F ↗ | FY 2022 Sep 30, 2022 20-F ↗ |
|---|---|---|---|---|
| Return on Common Equity (%) (%) |
-5.8%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-139%)
|
-26.5%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-277%)
|
1.1%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-92%)
|
— |
| Metric | FY 2025 Sep 30, 2025 20-F ↗ | FY 2024 Sep 30, 2024 20-F ↗ | FY 2023 Sep 30, 2023 20-F ↗ | FY 2022 Sep 30, 2022 20-F ↗ |
|---|---|---|---|---|
| Debt to Equity (x) |
0.35x
Good
↓
Good
Declining
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-42%)
|
1.01x
Caution
Caution
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Above avg (+68%)
|
0.90x
Fair
Fair
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Above avg (+49%)
|
— |
| Net Debt (USD) | $2.30M | $6.77M | $7.24M | $-731.18K |
| Metric | FY 2025 Sep 30, 2025 20-F ↗ | FY 2024 Sep 30, 2024 20-F ↗ | FY 2023 Sep 30, 2023 20-F ↗ | FY 2022 Sep 30, 2022 20-F ↗ |
|---|---|---|---|---|
| Sales/Revenue/Turnover (USD) | $9.85M | $11.51M | $13.57M | $19.71M |
| Depreciation Expense (USD) | $848.66K | $1.34M | $1.51M | $3.21M |
| Net Income, GAAP (USD) | $-1.07M | $-3.49M | $112.03K | $865.21K |
| Operating Cash Flow (USD) | $6.24M | $-2.23M | $2.21M | $-2.26M |
Secondary lens
Benchmark Lens
Compare WOK against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare WOK against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for WOK
No bullish signals detected
Profit Margin (%) is in the bottom quartile
Percentile Rankings
How WOK compares to all companies
Peer Comparison
WOK vs similar peers
Compare WOK with peers
Stack WOK against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 4 years · 4 quarters